Headquartered in Delray Beach, FL Fiscal year ends March NASDAQ: PETS 1800petmeds.com
PetMed Express, Inc. (dba PetMeds) is a direct-to-consumer pet healthcare company founded in 1996. Operating as a national online pet pharmacy licensed across all 50 U.S. states, the company offers prescription and non-prescription pet medications, compounded medications, OTC supplements, and pet nutrition products. PetMeds serves pet parents through its family of brands, including PetMeds.com and its subsidiary PetCareRx, focused on dogs, cats, and horses. The company is staffed with expert pharmacists and competes in the online pet pharmacy and wellness market, emphasizing value, convenience, and comprehensive pet health solutions. The company trades on NASDAQ under the ticker PETS. Updated
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital appreciation potential are essential for…
While Most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.…
The inflationary environment over the past few years has constricted consumer buying power, resulting in supplementary income requirements by many. For those who cannot augment their paychecks with additional part-time jobs but…
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In…
Friday's top analyst upgrades and downgrades included American Express, Caesars Entertainment, Carnival, Dish Network, DocuSign, Ford, Futu, Microsoft, Mobileye Global, Nvidia, SentinelOne, Snowflake, Vipshop and Walt Disney.
Are heavily shorted stocks that pay solid dividends an opportunity to pick up good stocks cheaply or are they too risky?
PetMed Express, Inc. (dba PetMeds) is a direct-to-consumer pet healthcare company founded in 1996. Operating as a national online pet pharmacy licensed across all 50 U.S. states, the company offers prescription and non-prescription pet medications, compounded medications, OTC supplements, and pet nutrition products.
The Wall Street consensus 12-month price target for PETS is $1.40.
